Latest news

Search
Categories
News archive

The Production of NLAB Saga® Stabilizes 

Nanologica has now approved a number of normal-sized batches from the large-scale production of the company’s silica for preparative chromatography, NLAB Saga®. Scaling up to large-scale production of silica at the contract manufacturer Sterling Pharma Solutions has been fraught with several challenges such as loss of material, which has previously been communicated. Although a couple of challenges remain, the company has now for the first time completed several large production batches in a row, which

Read more »

Bulletin from the AGM in Nanologica

Nanologica AB (publ) today 16 May 2024 held its Annual General Meeting in Stockholm, at which the following resolutions were adopted. Adoption of the income statement and balance sheet, disposition of result The Annual General Meeting adopted the income statement and balance sheet for the company and the group in accordance with the presented accounting documents and resolved, in accordance with the board´s proposal, that the accumulated loss of SEK -75,880,232 shall be carried forward.

Read more »

Nanologica’s Annual Report for 2023 Has Been Published

The annual report in Swedish and a translation in English is available on www.nanologica.com in a pdf format. The official original version of the annual report is prepared in Swedish in the European Single Electronic Format (ESEF). Swedish: https://nanologica.com/category/finansiella-rapporter/ English translation: https://nanologica.com/category/financial-reports/

Read more »